10-Q/A 1 redox1q10qa7391.txt AMENDED QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 Amendment 1 to FORM 10-Q QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended March 31, 2001 Commission File Number: 33-22142 ReDOX TECHNOLOGY CORPORATION Delaware Corporation 55-0681106 (State of Incorporation) (I.R.S. Employer Identification No.) 340 North Sam Houston Parkway East, Suite 250 Houston, Texas 77060 (713) 445-0020 Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES [X] NO [ ] APPLICABLE ONLY TO CORPORATE ISSUERS: Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date. CLASS NUMBER OF SHARES OUTSTANDING ON: March 31, 2001 Common Stock par value $0.00005 per share 62,887,311 PART I FINANCIAL INFORMATION ITEM 1. FINANCIAL STATEMENTS OF ReDOX TECHNOLOGY CORPORATION (Hereinafter referred to as Registrant or Company) Registrant prepared the accompanying financial statements from its own books and records. In management's opinion, these financial statements present fairly in all material respects Registrant's financial condition and changes therein as of March 31, 2001, and the results of operations and cash flows for the period, in conformity with generally accepted accounting principles. REDOX TECHNOLOGY CORPORATION (A Development Stage Company) BALANCE SHEET As of March 31, 2001 and December 31, 2000 (Restated)

2 REDOX TECHNOLOGY CORPORATION (A Development Stage Company) STATEMENT OF EXPENSES For the Three Months Ended March 31, 2001, and 2000, and the Period from April 9, 1993 (Inception) Through March 31, 2001 (Restated) (Unaudited)

3 REDOX TECHNOLOGY CORPORATION (A Development Stage Company) STATEMENT OF CASH FLOWS For the Three Months Ended March 31, 2001, and 2000, and the Period from April 9, 1993 (Inception) Through March 31, 2001 (Restated) (Unaudited) Inception

4 REDOX TECHNOLOGY CORPORATION (A Development Stage Company) NOTES TO FINANCIAL STATEMENTS (Restated) NOTE 1 BASIS OF PRESENTATION The accompanying unaudited interim financial statements of Redox Technology Corporation have been prepared in accordance with generally accepted accounting principles and the rules of the Securities and Exchange Commission ("SEC"), and should be read in conjunction with the audited financial statements and notes thereto contained in the Company's Annual Report filed with the SEC on Form 10-KSB. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim periods presented have been reflected herein. The results of operations for interim are not necessarily indicative of the results to be expected for the full year. Notes to the financial statements which would substantially duplicate the disclosure contained in the audited financial statements for the years ended December 31, 2000, 1999, and 1998, as reported in the 10-KSB, have been omitted. 5 ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS As previously reported, this corporation is in development stage and has not yet conducted any business so as to become an income producing entity. The Company continues to utilize capital borrowed from it principal shareholder, said capital's recognition as or equity contribution is being negotiated as required. Registrant's financial condition has not changed materially from December 31, 2000 to the date of the financial statements herewith provided. To the extent that the Company has incurred continuing expenses without any revenues having been generated, shareholder's equity would have suffered proportionately had it not been for the continuing infusion of capital from the Company director Richard Szymanski. Liquidity and Capital Resources: In January 2000, the Company issued 250,000 shares of its Common Stock to two former consultants to settle a lawsuit. The Company recorded the settlement expense of $125,000 based on the fair value of the Common Stock. In February of 2001, we issued Mr. Szymanski 11,937,311 shares of Common Stock in exchange for the promissory note dated August 2000 in the amount of $1,080,712 and the accrued interest. The face value of the note payable, plus interest, was converted to Common Stock. Mr. Szymanski has made assurances that he will continue to personally finance the Company, to the best of his ability, over the next 12 months on an as needed basis. Operating Data: There was no revenue from sales and ancillary income for the quarters ended March 31,2000 and March 30, 2001. Operating expenses were $161,722 for the first quarter of 2000 and were $50,583 for the first quarter of 2001. 7 PART II OTHER INFORMATION ITEM 1. LEGAL PROCEEDINGS None ITEM 2. CHANGES IN SECURITIES See Item 2 - Note 13 ITEM 3. DEFAULTS UPON SENIOR SECURITIES None ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS None ITEM 5. OTHER INFORMATION None ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K (S 229.30 of this chapter) None 8 ITEMS REPORTED ITEM 1. ACQUISITION/DISPOSITION OF ASSETS None ITEM 2. APPOINTMENT OF RECEIVER None ITEM 3. REGISTRANT/DISMISSAL OF CPA None ITEM 4. RESIGNATION OF DIRECTOR WITH DISAGREEMENT None ITEM 5. OTHER MATERIAL MATTERS (c) None 9 SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934 , the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. ReDOX TECHNOLOGY CORPORATION (Registrant) DATE: 8/14/01 /s/ Richard A. Szymanski ------------------------- Richard A. Szymanski President/Director 10

REDOX TECHNOLOGY CORP 10-Q/A